• LAST PRICE
    3.3500
  • TODAY'S CHANGE (%)
    Trending Down-0.1100 (-3.1792%)
  • Bid / Lots
    3.3500/ 3
  • Ask / Lots
    3.6100/ 5
  • Open / Previous Close
    3.4800 / 3.4600
  • Day Range
    Low 3.3500
    High 3.5300
  • 52 Week Range
    Low 3.0750
    High 6.7100
  • Volume
    294,854
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 3.46
TimeVolumeSCPH
09:32 ET6853.48
09:35 ET2003.52
09:37 ET13003.485
09:39 ET21753.49
09:42 ET53193.49
09:44 ET7003.495
09:51 ET5003.495
09:53 ET1003.51
09:55 ET22003.51
10:00 ET1003.525
10:04 ET5003.51
10:11 ET81363.505
10:13 ET18563.5
10:15 ET3003.495
10:18 ET1003.495
10:20 ET5003.5
10:22 ET2003.5
10:24 ET2003.51
10:26 ET35323.53
10:27 ET7003.515
10:29 ET76513.46
10:31 ET3003.44
10:33 ET1003.44
10:36 ET24003.47
10:40 ET2003.44
10:45 ET3003.43
10:47 ET6003.445
10:49 ET3003.445
10:54 ET10093.44
10:56 ET3003.44
10:58 ET1003.44
11:00 ET70383.4301
11:02 ET5003.435
11:03 ET2003.435
11:05 ET18153.46
11:07 ET2003.46
11:09 ET1003.47
11:12 ET1003.47
11:14 ET105323.5
11:16 ET6003.51
11:18 ET2003.505
11:20 ET12723.5
11:21 ET1003.5
11:25 ET6363.49
11:27 ET3003.49
11:30 ET1703.4999
11:32 ET125313.48
11:34 ET1003.48
11:36 ET1003.48
11:39 ET3173.48
11:41 ET1003.485
11:43 ET1003.49
11:45 ET1003.475
11:48 ET1003.47
11:50 ET18893.48
11:52 ET64883.49
11:54 ET12853.5
11:56 ET9393.48
12:15 ET1003.475
12:17 ET27003.48
12:19 ET3003.47
12:24 ET14253.435
12:26 ET71683.435
12:28 ET3003.43
12:30 ET1003.43
12:33 ET18533.43
12:35 ET28783.44
12:37 ET1003.44
12:39 ET3003.44
12:42 ET2003.44
12:44 ET3003.44
12:46 ET2003.44
12:48 ET17813.45
12:53 ET6173.4672
12:57 ET8693.46
01:00 ET1503.468079
01:02 ET2003.46
01:04 ET127213.495
01:06 ET4613.495
01:13 ET12003.495
01:18 ET8333.5
01:20 ET3003.505
01:22 ET1003.505
01:27 ET27053.495
01:29 ET35493.47
01:33 ET7623.455
01:36 ET12003.46
01:38 ET2003.46
01:40 ET2003.46
01:42 ET8993.46
01:49 ET5003.46
01:54 ET9793.44
02:00 ET2003.445
02:02 ET2003.445
02:07 ET1003.445
02:09 ET1663.45
02:16 ET8863.44
02:18 ET1003.44
02:20 ET3713.44
02:23 ET3003.4478
02:30 ET10663.45
02:36 ET1003.43
02:38 ET3563.43
02:39 ET12173.43
02:45 ET15003.415
02:48 ET2023.415
02:50 ET7763.41
02:56 ET2723.41
02:57 ET7003.42
03:01 ET1053.41
03:06 ET40513.39
03:08 ET16273.385
03:10 ET95213.4085
03:12 ET1473.39
03:15 ET7003.39
03:17 ET1003.385
03:19 ET31583.385
03:21 ET4413.39
03:24 ET16503.385
03:26 ET3003.38
03:28 ET4763.38
03:30 ET4413.385
03:32 ET2203.38
03:33 ET4273.38
03:35 ET9003.38
03:37 ET21653.39
03:39 ET8003.39
03:44 ET41623.385
03:46 ET11103.38
03:48 ET29073.37
03:50 ET14863.37
03:51 ET12093.37
03:53 ET17463.385
03:55 ET11663.38
03:57 ET66593.36
04:00 ET389853.35
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSCPH
scPharmaceuticals Inc
173.1M
-1.8x
---
United StatesBSEM
Biostem Technologies Inc
219.7M
22.1x
---
United StatesTELO
Telomir Pharmaceuticals Inc
132.4M
-5.2x
---
United StatesPGEN
Precigen Inc
257.8M
-1.6x
---
United StatesETST
Earth Science Tech Inc
39.8M
23.7x
---
United StatesUG
United-Guardian Inc
44.8M
12.9x
-9.92%
As of 2024-11-23

Company Information

scPharmaceuticals Inc. is a pharmaceutical company. The Company is focused on developing and commercializing products to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The Company develops, internally and through strategic partnerships, products and solutions that aim to expand and advance the outpatient care of select acute conditions. Its lead product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infuser. FUROSCIX is a formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self- administered subcutaneously via a single-use, disposable and wearable on-body delivery system. The Companay’s pipeline programs include SCP-111 (furosemide injection) 80mg/mL is an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home.

Contact Information

Headquarters
25 Burlington Mall Road, Suite 203BURLINGTON, MA, United States 01803
Phone
617-517-0730
Fax
302-655-5049

Executives

Independent Chairman of the Board
Jack Khattar
President, Chief Executive Officer, Director
John Tucker
Chief Financial Officer
Rachael Nokes
Independent Director
William Abraham
Independent Director
Mette Agger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$173.1M
Revenue (TTM)
$30.3M
Shares Outstanding
50.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.14
EPS
$-1.91
Book Value
$1.03
P/E Ratio
-1.8x
Price/Sales (TTM)
5.7
Price/Cash Flow (TTM)
---
Operating Margin
-253.39%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.